Intrinsiqq
ENvue Medical, Inc. logo

ENvue Medical, Inc. Insider Trading

FEED

⊜ Compare
Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in Jan 2023.

Net open-market
$0
0 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
0 / 0
executives and directors
Last open-market buy
Jan 2023
Jan 5, 2023

Get an email when FEED's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Jun 22No plan
    Christian Michael Glibert
    Other · sold 210,000 at $0.69
    145K
    100% of stake
  • Feb 2No plan
    Bank OF America Corp
    Large holder · sold 2,918 at avg $3.05
    9K
    1.2% of stake
  • Jan 14
    Christian Michael Glibert
    Large holder · bought 240,000 at $2.67
    641K
    New position
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch FEED, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Orthopedic, Prosthetic & Surgical Appliances & Supplies · Pick stocks to compare with FEED

CompareIntrinsic value
NTRBNutriband Inc.
$6.08-3.34%10
SPAISafe Pro Group Inc.
$3.05-3.79%40
AVRAnteris Technologies Ltd.
$6.12+9.29%10
CLGNCollPlant Biotechnologies Ltd.
$4.23+2.92%40
COCHEnvoy Medical, Inc.
$7.50+13.22%10
MLSSMilestone Scientific Inc.
$0.33+10.00%25
LGMKLogicMark, Inc.
No recent price35
VYCOVycor Medical Inc.
$0.05-3.85%50

Spot a number that looks wrong? Check it in FEED's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing FEED

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.